Maderazo, Cresencio B.
HRN: 14-92-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
AZITHROMYCIN 500MG TABLET (TAB)
11/22/2022
11/27/2022
PO
500 Mg
OD
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes